Refine
Has Fulltext
- yes (24)
Is part of the Bibliography
- yes (24)
Year of publication
Document Type
- Journal article (21)
- Conference Proceeding (2)
- Doctoral Thesis (1)
Language
- English (24) (remove)
Keywords
- positron emission tomography (8)
- PET (7)
- Positronen-Emissions-Tomografie (6)
- 18F-LMI1195 (3)
- norepinephrine transporter (3)
- sympathetic nervous system (3)
- 11C-HED (2)
- SPECT (2)
- ageing (2)
- diabetes (2)
- heart failure (2)
- molecular medicine (2)
- precision medicine (2)
- 11C-Hydroxyephedrine (1)
- 11C-hydroxyephedrine (1)
- 123I-metaiodobenzylguanidine (1)
- 18F-FDS (1)
- 18F-flurpiridaz (1)
- 18FFBnTP (1)
- 99mTc-DTPA (1)
- Alpha (1)
- Alpha power (1)
- Alzheimer’s disease (1)
- Body movement (1)
- Cardiovascular diseases (1)
- Cognition (1)
- Cognitive processing (1)
- ECG (1)
- FV45 (1)
- Glomerular filtration (1)
- HFmrEF (1)
- HMDP hydroxymethylene diphosphonate (1)
- Heart failure (1)
- Herz (1)
- Kognition (1)
- MPI (1)
- MRI (1)
- Mobie EEG (1)
- Myocardial-perfusion SPECT (1)
- Natural walking (1)
- Nierenfunktionsstörung (1)
- Positronenemissionstomografie (1)
- SPECT Scanner (1)
- Sodium-Glucose Cotransporters (SGLTs) (1)
- T-shaped π-π stacking (1)
- T-shaped π–π stacking (1)
- Walking (1)
- ZDF rats (1)
- \(^{18}\)F-FDG (1)
- \(^{18}\)F-fluorodeoxyglucose (1)
- alpha oscillations (1)
- amyloid-β (Aβ) (1)
- angiotensin II type 1 receptor (1)
- antidepressant (1)
- autonomic nervous system (1)
- benzylguanidine (1)
- biomarkers (1)
- blinks (1)
- butyrylcholinesterase (1)
- carbamate (1)
- cardiac (1)
- cardiac innervation imaging (1)
- cardiac neurohormonal system (1)
- cardiac sympathetic nervous system (1)
- coronary artery disease (1)
- diabetic cardiomyopathy (1)
- ejection fraction (1)
- endocrinology (1)
- enzyme kinetics (1)
- fluorine-18 (1)
- heart (1)
- heart failure with mid-range ejection fraction (1)
- hydroxyephedrine (1)
- left-ventricular function (1)
- locomotion (1)
- medium-sized animals (1)
- mobile EEG (1)
- motor entrainment (1)
- moycardial sympathetic innervation (1)
- myocardial perfusion imaging (1)
- myocardial sympathetic innervation imaging (1)
- nonhuman primates (1)
- nuclear cardiology (1)
- organic cation transporter (1)
- performance (1)
- personalized treatment (1)
- phaeochromocytoma (1)
- phenethylguanidine (1)
- pupil size (1)
- quality (1)
- radiotracer (1)
- radiotracer kinetics (1)
- radiotracers (1)
- rats (1)
- renal failure (1)
- renin-angiotensin system (1)
- saccades (1)
- scanner (1)
- single photon emission computed tomography: sympathetic nerve (1)
- skeletal (1)
- small animal SPECT (1)
- stem cells (1)
- stem-cell research (1)
- storage vesicle turnover (1)
- structure–activity relationships (1)
- sympathetic nerve (1)
- unilateral ureteral obstruction (1)
- valsartan (1)
- walking phase (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (22)
- Institut für Pharmazie und Lebensmittelchemie (6)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (5)
- Institut für Psychologie (2)
- Medizinische Klinik und Poliklinik I (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (4)
- Johns Hopkins School of Medicine, Baltimore, MD, USA (1)
- Johns Hopkins University School of Medicine (1)
- Johns Hopkins University School of Medicine, Baltimore, MD, U.S. (1)
- Johns Hopkins University, Baltimore, MD, U.S. (1)
- National Cardiovascular and Cerebral Center, Suita, Japan (1)
Background: Precise regional quantitative assessment of renal function is limited with conventional \(^{99m}\)Tc-labeled renal radiotracers. A recent study reported that the positron emission tomography (PET) radiotracer 2-deoxy-2-(\(^{18}\)F-fluorosorbitol (\(^{18}\)F-FDS) has ideal pharmacokinetics for functional renal imaging. Furthermore, (\(^{18}\)F-FDS is available via simple reduction from routinely used 2-deoxy-2-(\(^{18}\)F-fluoro-D-glucose ((\(^{18}\)F-FDG). We aimed to further investigate the potential of (\(^{18}\)F-FDS PET as a functional renal imaging agent using rat models of kidney diseases.
Methods: Two different rat models of renal impairment were investigated: Glycerol induced acute renal failure (ARF) by intramuscular administration of glycerol in hind legs and unilateral ureteral obstruction (UUO) by ligation of the left ureter. 24h after these treatments, dynamic 30 min 18F-FDS PET data were acquired using a dedicated small animal PET system. Urine 18F-FDS radioactivity 30 min after radiotracer injection was measured together with co-injected \(^{99m}\)Tc-diethylenetriaminepentaacetic acid (\(^{99m}\)Tc-DTPA) urine activity. Results: Dynamic PET imaging demonstrated rapid (\(^{18}\)F-FDS accumulation in the renal cortex and rapid radiotracer excretion via kidneys in control healthy rats. On the other hand, significantly delayed renal radiotracer uptake (continuous slow uptake) was observed in ARF rats and UUO-treated kidneys. Measured urine radiotracer concentrations of (\(^{18}\)F-FDS and \(^{99m}\)Tc-DTPA were well correlated (R=0.84, P<0.05).
Conclusions: (\(^{18}\)F-FDS PET demonstrated favorable kinetics for functional renal imaging in rat models of kidney diseases. Advantages of high spatiotemporal resolution of PET imaging and simple tracer production could potentially complement or replace conventional renal scintigraphy in select cases and significantly improve the diagnostic performance of renal functional imaging.
Brown adipose tissue (BAT) is an attractive therapeutic target to combat diabetes and obesity due to its ability to increase glucose expenditure. In a genetic rat model (ZDF fa/fa) of type-2 diabetes and obesity, we aimed to investigate glucose utilization of BAT by \(^{18}\)F-FDG PET imaging. Male Zucker diabetic fatty (ZDF) and Male Zucker lean (ZL) control rats were studied at 13 weeks. Three weeks prior to imaging, ZDF rats were randomized into a no-restriction (ZDF-ND) and a mild calorie restriction (ZDF-CR) group. Dynamic \(^{18}\)F-FDG PET using a dedicated small animal PET system was performed under hyperinsulinemic-euglycemic clamp. \(^{18}\)F-FDG PET identified intense inter-scapular BAT glucose uptake in all ZL control rats, while no focally increased \(^{18}\)F-FDG uptake was detected in all ZDF-ND rats. Mild but significant improved BAT tracer uptake was identified after calorie restriction in diabetic rats (ZDF-CR). The weight of BAT tissue and fat deposits were significantly increased in ZDF-CR and ZDF-ND rats as compared to ZL controls, while UCP-1 and mitochondrial concentrations were significantly decreased. Whitening and severely impaired insulin-stimulated glucose uptake in BAT was confirmed in a rat model of type-2 diabetes. Additionally, calorie restriction partially restored the impaired BAT glucose uptake.